REBECCA GREEN: Open Payments
NPI 1346825338 · LIGHTHOUSE POINT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 79 payments from 16 companies in 2025. Trend: 2023 $385 · 2024 $1,055 · 2025 $1,602
Food & beverage: $1,602
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $384 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $249 |
| Ardelyx, Inc. | 9 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $138 |
| Madrigal Pharmaceuticals | 5 | $122 |
| Janssen Biotech, Inc. | 5 | $112 |
| Aimmune Therapeutics, Inc. | 3 | $76 |
| Intercept Pharmaceuticals, Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| QOL Medical, LLC | 1 | $39 |
Products named: ENTYVIO, IBSRELA, XIFAXAN, RINVOQ, SKYRIZI, REZDIFFRA, TREMFYA, DUPIXENT.
Industry payments across FL — which companies pay providers there.
